Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Bristol-Myers Squibb discloses new HCV NS3 NS4A protease inhibitors

Oct. 3, 2014

Epigen Biosciences discloses novel LPA-1 receptors

Oct. 2, 2014

New LRRK2 inhibitors disclosed by Merck & Co.

Oct. 2, 2014

Gedeon Richter presents new histamine H3 receptor antagonists

Oct. 2, 2014

Merck KGaA divulges novel GCN2 inhibitors

Oct. 2, 2014

Novel fusion proteins patented by Pfizer as N. meningitidis vaccines

Oct. 2, 2014

Bristol-Myers Squibb discloses new NS5B inhibitors

Oct. 1, 2014

Merck KGaA prepares novel EIF2AK4/GSK-3 inhibitors

Oct. 1, 2014

Novel BACE inhibitors designed at Amgen

Oct. 1, 2014

Roche discloses new BTK inhibitors

Oct. 1, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...